Middle East And Africa Pharmaceutical Logistics Market: Forecast Analysis 2024-2032

Middle East And Africa Pharmaceutical Logistics Market: Forecast Analysis 2024-2032



Triton Market Research’s report suggests that the Middle East and Africa pharmaceutical logistics market is set to progress with a CAGR of 7.37% during the forecasted period 2024-2032.

The rising awareness about healthcare and increasing per capita income have significantly boosted the demand for healthcare services. The rapid population growth has further fueled the need for pharmaceuticals, attracting multinational pharmaceutical companies. The Middle East, in particular, heavily relies on pharmaceutical imports from countries like the UK, Switzerland, the US, France, and Germany. For instance, the UAE sources its pharmaceutical products from seventy-two countries, with ten countries accounting for 80% of its total imports. This dependence underscores the growing necessity for efficient pharmaceutical logistics services to meet the increasing demands.

Turkey dominates the regional market, recording $817.77 million in 2023

Pharmaceutical logistics companies play a crucial role alongside pharmaceutical firms in the storage and distribution of drugs, which has increased strategic initiatives among contenders. For instance, Turkish Cargo launched three innovative products for pharmaceutical logistics: TK Pharma Standard, TK Pharma Extra, and TK Pharma Advanced.

Turkey is home to more than 300 domestic and international pharmaceutical companies operating as producers and importers, primarily concentrated in Istanbul.

In 2020, Turkey imported approximately $5 billion worth of pharmaceutical products, making it one of the top 25 importers worldwide. This surge in exports is fueling the growth of Turkey’s pharmaceutical logistics market.

Market Forecast for United Arab Emirates and Saudi Arabia

The pharmaceutical logistics market in the United Arab Emirates (UAE) has experienced notable growth, positioning the country as a key player in the global pharmaceutical supply chain. Major companies like Sanofi, Novartis, and Pfizer have been drawn to the UAE due to its strategic location, advanced logistics infrastructure, and favorable business climate. For instance, Emirates Cargo reported nearly double-digit annual growth, with revenue from pharmaceutical transport surpassing AED 2 billion for the first time in 2021-22.

In Saudi Arabia, the government’s encouragement of generic substitution to control costs significantly boosts the pharmaceutical logistics market. Additionally, pharmaceutical transport relies heavily on road freight due to its low entry barriers. The market is primarily dependent on imports, with the government’s Vision 2030 economic policy allowing 100% foreign direct investment in the pharmaceutical sector, fostering demand for pharmaceutical logistics.

The market is sectioned in terms of logistics type, therapy area, component, and pharma type. The logistics type section includes cold chain and non-cold chain logistics.

Cold chain logistics is essential for preserving temperature-sensitive pharmaceutical products, ensuring they remain effective from manufacture to use. This meticulous process is vital for medications, vaccines, and biologics, which require strict temperature control to maintain their efficacy. The cold chain process encompasses multiple stages: manufacturing, packaging, storage, transportation, and distribution. Each stage demands careful planning and precise execution to maintain the required temperature. During transportation, products are typically shipped in temperature-controlled vehicles equipped with real-time monitoring devices.

The notable companies in the pharmaceutical logistics market consist of Agility Logistics, Cardinal Health Inc, DB Schenker, AP Moller–Maersk, Cencora (AmerisourceBergen), and CEVA Logistics.

Agility Logistics specializes in the construction, management, and leasing of various types of warehouses. The company also offers transportation, handling, distribution, and customs clearance services. Its business activities are categorized into two main segments: logistics & related services and infrastructure. In the logistics and related services segment, Agility provides a range of solutions, including freight forwarding, contract logistics, transportation, project logistics, and logistics for fairs and events. Agility operates globally, including in the Middle East and Africa. It is publicly traded on Boursa Kuwait and the Dubai Stock Exchange.

Latest from the Company:

In November 2023, Agility announced that the warehouses at its Agility Logistics Park in Abidjan became the first in Côte d’Ivoire and West Africa to receive EDGE Advanced certification for green buildings.


1. Middle East And Africa Pharmaceutical Logistics Market - Summary
2. Industry Outlook
2.1. Impact Analysis On The Pharmaceutical Logistics Market
2.1.1. Impact Of Covid-19
2.2. Porter’s Five Forces Analysis
2.2.1. Threat Of New Entrants
2.2.2. Threat Of Substitutes
2.2.3. Bargaining Power Of Buyers
2.2.4. Bargaining Power Of Suppliers
2.2.5. Competitive Rivalry
2.3. Key Buying Impact Analysis
2.3.1. Logistics Type
2.3.2. Services Offered
2.3.3. Mode Of Transportation
2.3.4. Application
2.3.5. Regulatory Compliance
2.3.6. Technological Capabilities
2.3.7. Cost
2.3.8. Reliability
2.3.9. Agility
2.4. Value Chain Analysis
2.4.1. Manufacturing
2.4.2. Storage
2.4.3. Transportation
2.4.4. Distribution
2.4.5. Monitoring Components
2.4.6. Consumption
2.5. Regulatory Outlook
2.6. Market Attractiveness Index
2.7. Key Market Strategies
2.7.1. Contracts & Partnerships
2.7.2. Business Expansions & Divestitures
2.7.3. Acquisitions & Mergers
2.7.4. Product Launches & Developments
2.8. Market Drivers
2.8.1. Escalating Demand For Temperature-regulated Solutions
2.8.2. Expanding Ocean Freight Services
2.8.3. Increasing Consumer Inclination Towards Over-the-counter Medications
2.9. Market Challenges
2.9.1. Necessity For Real-time Transparency And Dependability
2.9.2. Stringent Regulatory Mandates
2.10. Market Opportunities
2.10.1. Rising Opportunities In Cell & Gene Therapy Logistics Due To Increased Demand
2.10.2. Digital Transformation Paving The Way For Advancements In Pharmaceutical Logistics
2.10.3. Growing Demand For Clinical Trial Logistics
2.11. Analyst Perspective
3. Middle East And Africa Pharmaceutical Logistics Market - By Component
3.1. Storage
3.2. Transportation
3.3. Monitoring Components
4. Middle East And Africa Pharmaceutical Logistics Market - By Pharma Type
4.1. Branded Drugs
4.2. Generic Drugs
4.3. Otc
5. Middle East And Africa Pharmaceutical Logistics Market - By Logistics Type
5.1. Non-cold Chain Logistics
5.2. Cold Chain Logistics
6. Middle East And Africa Pharmaceutical Logistics Market - By Therapy Area
6.1. Communicable Diseases
6.2. Oncology
6.3. Diabetes
6.4. Cardiovascular Diseases
6.5. Autoimmune Diseases
6.6. Neurological Disorders
6.7. Pain Management
6.8. Respiratory Diseases
6.9. Other Therapy Areas
7. Middle East And Africa Pharmaceutical Logistics Market – By Country Outlook
7.1. Turkey
7.1.1. Turkey Pharmaceutical Logistics Market Forecast & Prospects
7.2. Saudi Arabia
7.2.1. Saudi Arabia Pharmaceutical Logistics Market Forecast & Prospects
7.3. United Arab Emirates
7.3.1. United Arab Emirates Pharmaceutical Logistics Market Forecast & Prospects
7.4. South Africa
7.4.1. South Africa Pharmaceutical Logistics Market Forecast & Prospects
7.5. Rest Of Middle East & Africa
7.5.1. Rest Of Middle East & Africa Pharmaceutical Logistics Market Forecast & Prospects
8. Competitive Landscape
8.1. Agility Logistics
8.1.1. Overview
8.1.2. Portfolio
8.1.3. Key Strengths
8.1.4. Key Challenges
8.2. Ap Moller – Maersk
8.2.1. Overview
8.2.2. Portfolio
8.2.3. Key Strengths
8.2.4. Key Challenges
8.3. Cardinal Health Inc
8.3.1. Overview
8.3.2. Portfolio
8.3.3. Key Strengths
8.3.4. Key Challenges
8.4. Cencora (Amerisourcebergen)
8.4.1. Overview
8.4.2. Portfolio
8.4.3. Key Strengths
8.4.4. Key Challenges
8.5. Ceva Logistics
8.5.1. Overview
8.5.2. Portfolio
8.5.3. Key Strengths
8.5.4. Key Challenges
8.6. Db Schenker
8.6.1. Overview
8.6.2. Portfolio
8.6.3. Key Strengths
8.6.4. Key Challenges
8.7. Deutsche Post Ag
8.7.1. Overview
8.7.2. Portfolio
8.7.3. Key Strengths
8.7.4. Key Challenges
8.8. Dsv
8.8.1. Overview
8.8.2. Portfolio
8.8.3. Key Strengths
8.8.4. Key Challenges
8.9. Fedex Corporation
8.9.1. Overview
8.9.2. Portfolio
8.9.3. Key Strengths
8.9.4. Key Challenges
8.10. Kuehne + Nagel
8.10.1. Overview
8.10.2. Portfolio
8.10.3. Key Strengths
8.10.4. Key Challenges
8.11. Marken (Acquired By Ups)
8.11.1. Overview
8.11.2. Portfolio
8.11.3. Key Strengths
8.11.4. 8key Challenges
8.12. Medline Industries Lp
8.12.1. Overview
8.12.2. Portfolio
8.12.3. Key Strengths
8.12.4. Key Challenges
8.13. Seko Logistics
8.13.1. Overview
8.13.2. Portfolio
8.13.3. Key Strengths
8.13.4. Key Challenges
8.14. United Parcel Service (Ups)
8.14.1. Overview
8.14.2. Portfolio
8.14.3. Key Strengths
8.14.4. Key Challenges
9. Research Methodology & Scope
9.1. Research Scope & Deliverables
9.2. Sources Of Data
9.3. Research Methodology
List Of Tables
Table 1: Middle East And Africa Pharmaceutical Logistics Market, By Country Outlook, Historical Years, 2020-2023 (In $ Million)
Table 2: Middle East And Africa Pharmaceutical Logistics Market, By Country Outlook, Forecast Years, 2024-2032 (In $ Million)
Table 3: List Of Contracts & Partnerships
Table 4: List Of Business Expansions & Divestitures
Table 5: List Of Acquisitions & Mergers
Table 6: List Of New Product Launches & Developments
Table 7: Middle East And Africa Pharmaceutical Logistics Market, By Component, 2024-2032 (In $ Million)
Table 8: Middle East And Africa Pharmaceutical Logistics Market, By Pharma Type, 2024-2032 (In $ Million)
Table 9: Middle East And Africa Pharmaceutical Logistics Market, By Logistics Type, 2024-2032 (In $ Million)
Table 10: Middle East And Africa Pharmaceutical Logistics Market, By Therapy Area, 2024-2032 (In $ Million)
Table 11: Middle East And Africa Pharmaceutical Logistics Market, By Country Outlook, 2024-2032 (In $ Million)
List Of Figures
Figure 1: Porter’s Five Forces Analysis
Figure 2: Key Buying Impact Analysis
Figure 3: Value Chain Analysis
Figure 4: Middle East And Africa Pharmaceutical Logistics Market, By Component, 2023 & 2032 (In %)
Figure 5: Middle East And Africa Pharmaceutical Logistics Market, By Storage, 2024-2032 (In $ Million)
Figure 6: Middle East And Africa Pharmaceutical Logistics Market, By Transportation, 2024-2032 (In $ Million)
Figure 7: Middle East And Africa Pharmaceutical Logistics Market, By Monitoring Components, 2024-2032 (In $ Million)
Figure 8: Middle East And Africa Pharmaceutical Logistics Market, By Pharma Type, 2023 & 2032 (In %)
Figure 9: Middle East And Africa Pharmaceutical Logistics Market, By Branded Drugs, 2024-2032 (In $ Million)
Figure 10: Middle East And Africa Pharmaceutical Logistics Market, By Generic Drugs, 2024-2032 (In $ Million)
Figure 11: Middle East And Africa Pharmaceutical Logistics Market, By Otc, 2024-2032 (In $ Million)
Figure 12: Middle East And Africa Pharmaceutical Logistics Market, By Logistics Type, 2023 & 2032 (In %)
Figure 13: Middle East And Africa Pharmaceutical Logistics Market, By Non-cold Chain Logistics, 2024-2032 (In $ Million)
Figure 14: Middle East And Africa Pharmaceutical Logistics Market, By Cold Chain Logistics, 2024-2032 (In $ Million)
Figure 15: Middle East And Africa Pharmaceutical Logistics Market, By Therapy Area, 2023 & 2032 (In %)
Figure 16: Middle East And Africa Pharmaceutical Logistics Market, By Communicable Diseases, 2024-2032 (In $ Million)
Figure 17: Middle East And Africa Pharmaceutical Logistics Market, By Oncology, 2024-2032 (In $ Million)
Figure 18: Middle East And Africa Pharmaceutical Logistics Market, By Diabetes, 2024-2032 (In $ Million)
Figure 19: Middle East And Africa Pharmaceutical Logistics Market, By Cardiovascular Diseases, 2024-2032 (In $ Million)
Figure 20: Middle East And Africa Pharmaceutical Logistics Market, By Autoimmune Diseases, 2024-2032 (In $ Million)
Figure 21: Middle East And Africa Pharmaceutical Logistics Market, By Neurological Disorders, 2024-2032 (In $ Million)
Figure 22: Middle East And Africa Pharmaceutical Logistics Market, By Pain Management, 2024-2032 (In $ Million)
Figure 23: Middle East And Africa Pharmaceutical Logistics Market, By Respiratory Diseases, 2024-2032 (In $ Million)
Figure 24: Middle East And Africa Pharmaceutical Logistics Market, By Other Therapy Areas, 2024-2032 (In $ Million)
Figure 25: Middle East And Africa Pharmaceutical Logistics Market, By Country Outlook, 2023 & 2032 (In %)
Figure 26: Turkey Pharmaceutical Logistics Market 2024-2032 (In $ Million)
Figure 27: Saudi Arabia Pharmaceutical Logistics Market 2024-2032 (In $ Million)
Figure 28: United Arab Emirates Pharmaceutical Logistics Market 2024-2032 (In $ Million)
Figure 29: South Africa Pharmaceutical Logistics Market 2024-2032 (In $ Million)
Figure 30: Rest Of Middle East & Africa Pharmaceutical Logistics Market 2024-2032 (In $ Million)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings